ARTL Artelo Biosciences, Inc.

NSC
$4.54

Artelo Biosciences, Inc. (ARTL) is expected to report earnings on November 11, 2026, before the market open.

Artelo Biosciences Reported Earnings
Thursday, August 13, 2026 · 8:00 AM ET
Earnings Date
Nov 11
Wednesday · 8:00 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Artelo Biosciences, Inc.

Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting lipid signaling pathways including the endocannabinoid system.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.